Rwanda has officially commissioned Africa's first end-to-end AI-powered mRNA biotechnology hub in Kigali's Special Economic Zone.
Constructed using prefabricated BioNTainers, the high-tech facility leverages predictive neural networks to design and synthesize targeted mRNA vaccines for malaria, tuberculosis, and endemic viral strains that disproportionately affect tropical regions.
Crucially, the facility's sequencing pipelines are trained on diverse African genomic data gathered in partnership with universities across Rwanda, Senegal, and Uganda, ensuring that therapeutics are optimized for local genetic profiles.
President Paul Kagame remarked: "For too long, Africa waited at the end of the line for life-saving therapeutics. Today, we manufacture our own health sovereignty."